pubmed-article:15662154 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15662154 | lifeskim:mentions | umls-concept:C0011847 | lld:lifeskim |
pubmed-article:15662154 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:15662154 | pubmed:dateCreated | 2005-1-21 | lld:pubmed |
pubmed-article:15662154 | pubmed:abstractText | The atypical antipsychotics have been recognized to induce diabetes mellitus and ketoacidosis in the adult psychiatric population. This report notes the onset of weight gain, diabetes, and apparent ketosis in a prepubertal boy diagnosed with bipolar disorder and treated with olanzapine. The hyperglycemia rapidly normalized after discontinuation of the olanzapine. Within 2 years, the diabetes recurred. In spite of the normalization of blood-glucose levels, urine ketone tests remained positive and were explained by the fact that patients taking valproic acid may have a false-positive urine test for ketones. Regular monitoring of glucose should be considered in children and adolescents who gain weight while treated with atypical antipsychotics. | lld:pubmed |
pubmed-article:15662154 | pubmed:language | eng | lld:pubmed |
pubmed-article:15662154 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15662154 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15662154 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15662154 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15662154 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15662154 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15662154 | pubmed:issn | 1044-5463 | lld:pubmed |
pubmed-article:15662154 | pubmed:author | pubmed-author:CookeDavid... | lld:pubmed |
pubmed-article:15662154 | pubmed:author | pubmed-author:RiddleMark... | lld:pubmed |
pubmed-article:15662154 | pubmed:author | pubmed-author:CourvoisieHel... | lld:pubmed |
pubmed-article:15662154 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15662154 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:15662154 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15662154 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15662154 | pubmed:pagination | 612-6 | lld:pubmed |
pubmed-article:15662154 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:15662154 | pubmed:meshHeading | pubmed-meshheading:15662154... | lld:pubmed |
pubmed-article:15662154 | pubmed:meshHeading | pubmed-meshheading:15662154... | lld:pubmed |
pubmed-article:15662154 | pubmed:meshHeading | pubmed-meshheading:15662154... | lld:pubmed |
pubmed-article:15662154 | pubmed:meshHeading | pubmed-meshheading:15662154... | lld:pubmed |
pubmed-article:15662154 | pubmed:meshHeading | pubmed-meshheading:15662154... | lld:pubmed |
pubmed-article:15662154 | pubmed:meshHeading | pubmed-meshheading:15662154... | lld:pubmed |
pubmed-article:15662154 | pubmed:meshHeading | pubmed-meshheading:15662154... | lld:pubmed |
pubmed-article:15662154 | pubmed:meshHeading | pubmed-meshheading:15662154... | lld:pubmed |
pubmed-article:15662154 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15662154 | pubmed:articleTitle | Olanzapine-induced diabetes in a seven-year-old boy. | lld:pubmed |
pubmed-article:15662154 | pubmed:affiliation | Division of Child and Adolescent Psychiatry Division, Department of Psychiatry, Johns Hopkins Medical Institutions, Baltimore, MD 21287-3325, USA. hcourvoi@jhmi.ed | lld:pubmed |
pubmed-article:15662154 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15662154 | pubmed:publicationType | Case Reports | lld:pubmed |